New Israeli Blood Test Accurately Detects Early Breast Cancer
Summarized from Ynetnews by baba
Israeli researchers have developed a new blood test that can detect early-stage breast cancer with 95% accuracy and predict recurrence risk with 81% accuracy. The test analyzes epigenetic signatures in the bloodstream, offering a non-invasive alternative to traditional methods. Published in Nature, the study involved scientists from the Weizmann Institute of Science and Hebrew University. This breakthrough could significantly improve cancer screening and treatment monitoring.
The story in 6 lines · by baba
- A new Israeli blood test detects early-stage breast cancer with 95% accuracy.
- The test also predicts the risk of cancer recurrence with 81% accuracy.
- Researchers identified unique epigenetic signatures of aggressive cancer cells in the blood.
- The technology uses single-molecule microscopy and AI to analyze blood samples.
- The findings were published in the scientific journal Nature.
- The study involved scientists from the Weizmann Institute and Hebrew University.
Ynetnews publishes in English. The key points are summarized above. Read Ynetnews’s full report from the link at the top of the page.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 1Right 1
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
